Over the years I’ve been keeping my eyes open for advertising by stem cell clinics and lately the trend is big splashy ads in mainstream media including large daily newspapers such as the SacBee, the San Francisco Chronicle, and now the Seattle times (see below from today’s). These kinds of big ad buys on front or […]
Money talks: stem cell clinic ads mushrooming in mainstream media Read More »
A list of stuff for your weekend reading enjoyment ranging from research pubs to news to commentary. Electrical Stimulation Steers Neural Stem Cells. Way to go UC Davis team; see image at right. Stem cell therapies: medical experts call for strict international rules. A team calls for global efforts. Stem cells in court: historical trends in US
TGIF: Stem cell and science weekend reads Read More »
Can a stem cell clinic business get FDA RMAT designation? At least one announced it was trying, but now seems to have given up. Stem cell clinic business US Stem Cell, Inc. has reportedly announced that it is at least temporarily abandoning its efforts at getting Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. The
US Stem Cell bid for FDA RMAT rejected? Read More »
In December of each year I make a list of stem cell predictions for the coming year, and I made 20 such predictions for 2017 so I’m wondering how I’m doing so far on these now that it’s June. Below is my work-in-progress scorecard for these so far. Positive news from Asterias on trial for stem cell-based
2017 stem cell predictions: score card at 1/2-way point Read More »
Many stem cell clinics are in a bind in 2017 in the new RMAT approval reality. Stem cell clinics say that they only want to help people by providing stem cell therapies to patients in a speedier way that they claim getting FDA approval for a trial just doesn’t allow, but that doesn’t ring true.
FDA warp speed RMAT approval nukes stem cell clinic excuses Read More »
Is there a proliferating stem cell fake news problem in the biotech world? More broadly, the SEC is cracking down on the mess that is fake biotech news, but what about fake news on stem cell biotechs more specifically? Already in the past year I’ve seen examples of possible stem cell fake news. Hyped press releases (PR)
Stem cell fake news driving biotech investors or vice versa…or what? Read More »
Will Texas go it alone by giving stem cell clinics free rein or will it break new ground by passing laws that promote reasonable stem cell clinical practices with safeguards? Some middle ground? It’s a dramatic moment for the stem cell field as legislation under consideration in Texas could have big impact on stem cell businesses
Battle over Texas stem cell legislation flares as it nears end Read More »
The Texas Legislature is considering three risky bills that would give free rein to stem cell clinics to profit big time off of patients by selling unproven and unapproved “stem cell treatments” that have little if any science behind them. I call one of these bills “Right to Profit” for clinics, which if these became
Risky Pro-Stem Cell Clinic Bills Still Alive in Texas Legislature Read More »
Today’s post is the last of a three-part series on the Burt stem cell trials at Northwestern. This piece is focused on funding and the future of the trial, and also includes perspectives from patients. You can read Part 1 here and Part 2 here, which focused on issues related to potential encouragement of patient fundraising that unintentionally releases
Burt Northwestern Stem Cell MS Trial Part 3: Funding, Patient Perspectives, & the Future Read More »
Dr. Richard Burt of Northwestern University has been doing cutting edge research on the use of stem cells for autoimmune disorders for more than a decade. The core idea behind the work that Burt and other research teams are doing is that stem cells may have revolutionary potential to somehow counteract the autoimmunity that causes
Burt Northwestern Stem Cell MS Trial Part 1: Big Promise & Tough Questions Read More »